Heparin induced thrombocytopenia antibodies in Covid-19
Am J Hematol
.
2020 Oct;95(10):E295-E296.
doi: 10.1002/ajh.25935.
Epub 2020 Aug 8.
Authors
Rushad Patell
1
,
Adeel M Khan
1
,
Thomas Bogue
1
,
Mwanasha Merrill
2
,
Anita Koshy
1
,
Poorva Bindal
1
,
Robin Joyce
1
,
William C Aird
1
,
Donna Neuberg
3
,
Kenneth A Bauer
1
,
Jeffrey I Zwicker
1
Affiliations
1
Division of Hematology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
2
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
3
Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
PMID:
32658337
PMCID:
PMC7405086
DOI:
10.1002/ajh.25935
No abstract available
Keywords:
Covid-19; anticoagulation; heparin induced thrombocytopenia.
Publication types
Letter
Grants and funding
T32 HL007917/HL/NHLBI NIH HHS/United States